Search results for: “biotech”
-
Novartis to acquire Chinook Therapeutics for $3.5 billion
•
Novartis, the Swiss pharmaceutical giant, has announced its agreement to acquire Chinook Therapeutics, a biotech firm based in…
-
Illumina CEO Francis deSouza Resigns Following Activist Investor’s Failed Ouster Attempt
•
Illumina, a leading biotech company, announced on Sunday that CEO Francis deSouza has resigned from his position. This…
-
Frontier IP sells more Exscientia shares for $1.86 million
•
LONDON, UK: Frontier IP, a UK-based company that helps commercialise intellectual property, has announced that it has sold…
-
Dr Debra Barker appointed interim CEO of Destiny Pharma as Neil Clark steps down
•
BRIGHTON, UNITED KINGDOM: Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development…
-
Oncimmune sells its diagnostic business to Freenome for £13 million
•
LONDON, UK: Oncimmune Holdings has sold its diagnostic business, including the EarlyCDT® Lung blood test and antibody platform,…
-
Antisense Therapeutics Limited appoints Dr James Garner as CEO and MD
•
SYDNEY, AUSTRALIA: The Board of Directors of Antisense Therapeutics Limited announced the appointment of Dr James Garner MBBS…
-
Kazia Therapeutics CEO Dr James Garner Resigns, Dr John Friend Assumes Role
•
SYDNEY, AUSTRALIA: Kazia Therapeutics Limited , an oncology-focused drug development company, today announced that Chief Executive Officer and…
-
Woodoo raises $31M to turn discarded wood into sustainable building materials
•
Paris-based biotechnology startup Woodoo has raised $31 million in funding to expand its technology platform that transforms discarded…
-
Merck to acquire Prometheus Biosciences for $10.8bn to bolster immunology presence
•
Prometheus Biosciences Inc is set to be acquired by Merck & Co for approximately $10.8 billion, according to…
-
Moderna forecasts $8-15 billion in sales from its respiratory vaccines by 2027
•
Moderna announced on Tuesday that it expects to generate between $8 billion and $15 billion in sales from…
-
Pfizer acquires Seagen for $43 billion to produce record scale cancer drug
•
Pfizer CEO Albert Bourla on Monday said the pharmaceutical giant will be able to deliver Seagen’s cancer therapy…
-
WPP acquires 3K Agentur für Kommunikation, a German PR agency
•
LONDON, UK: WPP Plc has acquired 3K Agentur für Kommunikation (3K), one of the leading healthcare specialist PR…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.